期刊文献+

^(18)F-FDG PET/CT在原发性肝癌介入治疗中的价值 被引量:15

The clinical value of()^(18)F-FDG PET/CT on interventional therapy of primary hepatocellular carcinomas
暂未订购
导出
摘要 目的评价18F-FDG PET/CT对介入治疗后残留病灶的作用;分析碘油沉积状态和肿瘤残留灶的关系;探讨18F-FDG PET/CT的应用范围及在介入治疗中的价值。方法22例结节型或巨块型原发性肝癌患者(平均最大径8.1 cm),在动脉栓塞化疗(TACE)或动脉栓塞化疗序贯联合射频消融(RFA)治疗后行18F-FDG PET/CT检查。检查结果阳性者,分析残留灶和沉积碘油的关系,并在PET-CT指导下对其作进一步的介入治疗。检查结果阴性者,用影像学和血清AFP随访6个月,以判断是否为真阴性。结果全组有21例患者经介入治疗后病灶内有碘油沉积。其中3例TACE后的病灶在有无碘油沉积的部位均可见残留灶。18例TACE序贯RFA治疗的病例中有11例存在残留灶,其中9例位于碘油沉积区和非碘油沉积区;2例残留灶仅存在于非碘油沉积区;另外7例PET/CT显示阴性,但其中1例经随访证实为假阴性。按照PET/CT所示的残留灶作进一步的介入治疗,又有5例存在残留灶的患者达到了局部根治。结论18F-FDG PET/CT对大肝癌介入治疗后的残留病灶探测具有较高的灵敏度。介入治疗后的病灶,无论是碘油沉积区还是非碘油沉积区都可能有残留病灶存在。18F-FDG PET/CT可以用于介入治疗后的疗效评价,并能对进一步的介入治疗起到靶向指导作用。 Objective To determine the sensitivity of fluorodeoxyglucose positron emission tomography/ computerized tomography (^18F-FDG-PET/CT) for detecting the residual HCC after interventional therapy and to analyze the lipiodol-accumulated and lipiodol-unaccumulated fields for localization of the residual tumor; together with exploration of field for ^18F-FDG-PET/CT in interventional therapy. Methods 22 HCC patients with average lesion diameter 8.1 cm received ^18F-FDG-PET/CT examination after transcatheter hepatic arterial chemoembolization (TACE) or the treatment of TACE following radiofrequency ablation( RFA). The findings of relation between residual and lipiodol-accumulated field could lead to perform more interventional therapy for the residual under PET-CT guidance. For patients with negative finding should be followed up with imaging examination and alpha-fetoprotein (AFP) for the sexelusion. Results The lesions of 21 cases showed more or less lipiodol deposition, including 3 cases with ^18F-FDG-PET/CT scanning after TACE which showed tracer concentrations indicating the existance of the residuals in the lipiodol-accumulated and lipiodol-unaccumulated fields. 18 cases received ^18F-FDG-PET/CT scanning after TACE following RFA showed residuals in 11. The residuals in 9 of the 11 cases distributed in the region of lipiodol-accumulated and lipiodol-unaccumulated fields and the residuals of the rest 2 cases only occurred in the lipiodol-unaccumulated area. The imagings of ^18F-FDG-PET/CT scanning for 9 cases were negative, but with falsenegative in 1 case. After all the sensitivity of ^18F-FDG-PET/CT scanning was 93.3 % . Moreover, another 5 cases with residual lesions achieved local radical therapy after RFA under ^18F-FDG-PET/CT guidance. Conclusions ^18F-FDG PET/CT has higher sensitivity for the detection of residuals of large HCC after interventional therapy. Residuals might exist in lipiodol-accumulated or lipiodol-unaccumulated fields and therefore ^18F-FDG PET/CT may provide the assessment for the therapeutic effect of HCC after interventional therapy and guidance for more treatments.
出处 《介入放射学杂志》 CSCD 2005年第6期588-591,共4页 Journal of Interventional Radiology
关键词 原发性肝癌 经动脉导管栓塞化疗 射频消融 正电子发射断层扫描 Primary hepatocellular carcinomas Transcatheter hepatic arterial chemoembolization Radiofrequency ablation Positron emission tomography
  • 相关文献

参考文献11

  • 1史宪杰,李开宗,高志清,付由池,窦科峰,陈勇,赵青川,管文贤,贺洪德,韩国宏,马福成,晏培松.经导管肝动脉栓塞化疗后肝癌二步切除的临床与病理特点分析[J].中国肿瘤临床,2000,27(3):226-227. 被引量:3
  • 2Gerald D,Michael C,Robert A,et al.Minimally Invasive Treatment of Malignance Hepatic Tumors:At the Threshold of a Major Breakthrough.Radiographics 2000; 20:9-27.
  • 3魏昊,吴华.PET显像在原发性肝癌中的应用[J].放射学实践,2004,19(12):917-919. 被引量:5
  • 4Fukuda K,Taniguchi H,Koh T,et al.Relationships between oxygen and glucose metabolism in human liver tumours:positron emission tomography using (15) O and (18) F-deoxyglucose.Nucl Med Commun.2004,25:577-583.
  • 5Torizuka T,Tamaki N,Inokuma T,et al.Value of fluorine-18-FDGPET to monitor hepatocellular carcinoma after interventional therapy.J Nucl Med,1994,35:1965-1969.
  • 6孔令山,尤天庚,潘文舟,张致峰,尚玉琨,谢明萱,王少雁,崔斌.^(18)F-FDGPET显像监测肝癌TACE治疗疗效[J].中国医学影像学杂志,2002,10(5):335-337. 被引量:6
  • 7Anderson GS,Brinkmann F,Soulen MC,et al.FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.Clin Nucl Med,2003,28:192-197.
  • 8商健彪,李彦豪,刘方颖,王全师,曾庆乐,郭晓君,陈勇,吴湖炳.^(18)F-FDG PET显像在肝细胞癌介入治疗后残留病灶检出中的应用[J].中华核医学杂志,2004,24(6):325-327. 被引量:19
  • 9Delbeke D,Martin WH,Sandler MP,et al.Evaluation of benign vs malignant hepatic lesions with positron emission tomography.Arch Surg,1998,133:510-516.
  • 10Goldberg SN,Gazelle GS,Mueller PR.Thermal ablation therapy for focal malignancy:a unified approach to underlying principles,techniques,and diagnostic imaging guidance.AJR,2000,174:323-331.

二级参考文献26

  • 1郑可国,许达生,李子平,全显跃.肝癌CT“密度更低区”对栓塞治疗后碘油潴留形态的影响[J].中华放射学杂志,1995,29(4):243-247. 被引量:19
  • 2Chung JK, Lee YJ,Kim C, et al. Mechanisms related to [18F]fluorodeoxyglucose uptake of human colon cancers transplanted in nude mice[J]. J Nucl Med,1999,40(2) :339-346.
  • 3Aloj L,Caraco C,Jagoda E,et al. Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431and T47D cells in culture[J]. Cancer Res, 1999,59(18) :4709-4714.
  • 4Wudel LJ Jr,Delbeke D,Morris D,et al. The role of [18F] fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma[J]. Am Surg, 2003,69 (2): 117-124.
  • 5Iwata Y,Shiomi S,Sasaki N, et al. Clinical usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in the diagnosis of liver tumors[J]. J Nucl Med,2003,44(2):213-221.
  • 6Khan MA, Combs CS,Brunt EM, et al. Positron emission tomography scanning in the evaluation of hepatocellular carcinoma[J].Ann Nucl Med,2000,14(2) :121-126.
  • 7Trojan J,Schroeder O,Raedle J,et al. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma[J].Liver, 2000,20 (6): 487-490.
  • 8Enomoto K, Fukunaga T, Okazumi S, et al. Can fluorodeoxyglucose-positron emission tomography evaluate the functional differentiation of hepatocellular carcinoma[J]. J Nucl Med, 1994,35(5) :818-823.
  • 9Delbeke D,Martin WH,Sandler MP,et al. Evaluation of benign vs malignant hepatic lesions with positron emission tomography[J].Anticancer, 1999,19(5C): 4443-4450.
  • 10Ho CL,Yu SC,Yeung DW. llC-acetate PET imaging in hepatocellular carcinoma and other liver masses[J]. J Nucl Med, 2003,44(2) :222-223.

共引文献27

同被引文献130

引证文献15

二级引证文献119

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部